Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001078782-13-001292
Filing Date
2013-07-01
Accepted
2013-07-01 17:44:16
Documents
1
Period of Report
2013-06-27

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 5049
  Complete submission text file 0001078782-13-001292.txt   6633
Mailing Address 12626 HIGH BLUFF DR. SUITE 150 SAN DIEGO CA 92130
Business Address 12626 HIGH BLUFF DR. SUITE 150 SAN DIEGO CA 92130 858-704-4040
Imprimis Pharmaceuticals, Inc. (Issuer) CIK: 0001360214 (see all company filings)

EIN.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1440 28TH STREET SUITE 9 BOULDER CO 80303
Business Address
Kammer Robert J (Reporting) CIK: 0001542484 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35814 | Film No.: 13945805